Author: Kathir J

  • 30% global growth drive: China’s 15th Five-Year Plan kicks off with confidence

    As 2026 marks the beginning of China’s 15th Five-Year Plan (2026–2030) amid rising global volatility and fragmentation, CGTN published an analysis exploring how China will sustain steady economic growth, and what drives the resilience of the world’s second-largest economy.

    Despite mounting external headwinds, China’s economy has demonstrated “remarkable resilience,” Marshall Mills, IMF’s senior resident representative to China, said late 2025. Noting that China contributes around 30 percent to global growth, he said the country’s steady outlook provides significant support to the world economy at a time of heightened uncertainty.

    As 2026 opens the first year of China’s 15th Five-Year Plan (2026–2030), policymakers have laid out a clear roadmap. At the Central Economic Work Conference at the end of 2025, Chinese President Xi Jinping set the overall tone for this year’s economic policy as “pursuing progress while maintaining stability, and improving quality and efficiency.”

    “There are many tasks on the economic agenda for 2026. We must grasp the key points and ensure coordinated progress,” Xi said.

    In a world marked by volatility and fragmentation, China’s strategy centers on deepening structural reform, strengthening the business environment and accelerating technological innovation.

    Stable policies underpin economic growth

    China’s top-level policy framework provides a strong institutional foundation for innovation-driven development. This stability and predictability not only supports domestic growth but also reduces uncertainty for businesses and strengthens market confidence.

    Over the years, China has elevated scientific and technological self-reliance to a strategic priority and set the goal of building a global science and technology powerhouse by 2035.

    This vision has been backed by concrete policy measures. Authorities have advanced major national science projects and laboratories, positioned enterprises as the primary drivers of innovation, strengthened collaboration among industry, universities and research institutes, and improved support mechanisms through tax incentives, R&D subsidies, talent programs and science-and-technology finance initiatives.

    At the same time, efforts to improve the business environment and invigorate the private sector have continued. Measures include expanded financing channels, tax and fee cuts, relaxed market access and stronger legal protection.

    In January last year, the country’s top economic planner, the National Development and Reform Commission (NDRC), released guidelines for building a unified national market to reduce transaction costs and improve factor mobility nationwide.

    Meanwhile, China’s national lawmakers last April passed the country’s first fundamental law dedicated to promoting the private sector, seeking to ensure fair competition, improve financing access and strengthen legal protections for private enterprises. China has also fully removed foreign investment access restrictions in the manufacturing sector and further shortened its negative list for foreign investment.

    For the 15th Five-Year Plan period, building a modern industrial system, fostering new quality productive forces, expanding domestic demand and advancing higher-level opening-up have been placed at the forefront.

    Strong foundations, vast potential

    Recent data underscores the effectiveness of this policy framework. In 2025, China’s GDP reached 140.19 trillion yuan (about $20.13 trillion), up 5 percent year on year, while foreign trade totaled 45.47 trillion yuan, marking nine consecutive years of growth.

    Liu Shangxi, vice chairman of the China Macroeconomics Society, said the performance reflects Chinese economy’s internal resilience despite external disruptions.

    Beyond headline figures, structural upgrading has accelerated. Traditional industries have stepped up digital and green transformation, while strategic emerging sectors – including next-generation information technology, high-end equipment manufacturing and new energy vehicles – have expanded rapidly.

    Green transition has become a defining feature of this shift. In 2025, China’s new energy vehicle output exceeded 16 million units, maintaining its global lead for the 11th consecutive year. The country has also built the world’s largest and most comprehensive renewable energy industrial chain. Energy consumption per unit of GDP has fallen 11.6 percent compared with 2020, equivalent to cutting roughly 1.1 billion tonnes of carbon dioxide emissions.

    Meanwhile, technological innovation is increasingly embedded across industrial chains. Taking AI as an example, official data shows that by early 2026, China had more than 6,000 artificial intelligence companies, with the core AI industry surpassing 1.2 trillion yuan in scale – up nearly 30 percent year on year. Domestic open-source large models have recorded over 10 billion cumulative global downloads, signaling widespread industrial integration.

    With its vast domestic market, complete industrial system, deep talent pool and strengths in digital and green sectors, China has built a comprehensive competitive edge, Liu noted. These fundamentals, he said, will not only sustain the world’s second-largest economy, but also inject greater predictability and stability into an increasingly uncertain global landscape.

    https://news.cgtn.com/news/2026-02-28/30-global-growth-drive-China-s-15th-FYP-kicks-off-with-confidence-1L83YGIBh8Q/p.html

  • RD6 PHEV Launches in Costa Rica as Geely RIDDARA Expands Its Latin America Footprint

    Hangzhou, China – Recently, Geely RIDDARA officially launched the RD6 PHEV in Costa Rica, marking the brand’s third model in the market following the RD6 and RD6 Econ. With three products now available locally, Geely RIDDARA has reinforced its leading position in Costa Rica’s new energy pickup segment.

    The Costa Rica launch marks another step in Geely RIDDARA’s accelerating expansion across Latin America, building a presence across multiple markets and usage scenarios. In Chile, the RD6 has performed strongly in high-intensity applications such as mining since entering the market in 2024. The introduction of the RD6 PHEV in December 2025 further strengthened the brand’s competitiveness among commercial customers.

    In Uruguay, the RD6 has steadily gained traction with individual users since its 2024 launch, supported by the rollout of the RD6 Econ in August 2025, which continues to drive market share growth. Panama, Colombia, and Bolivia also completed product introductions during 2025, marking broader regional expansion.

    As its Latin America footprint continues to grow, Geely RIDDARA is advancing its global presence in parallel. To date, the brand has entered more than 60 countries and regions across Latin America, Asia-Pacific, the Middle East, Africa, and Europe. Its global lineup now comprises three core models — RD6, RD6 Econ, and RD6 PHEV — covering both pure electric and plug-in hybrid powertrains.

    This global expansion is underpinned by Geely RIDDARA’s established new energy technology base. Backed by Geely Group’s R&D capabilities, the brand has developed China’s first native electric pickup platform and introduced EM-P hybrid technology into the pickup segment. These innovations enable scalable, market-ready new energy solutions worldwide.

    Designed around the concept “Function like a Pickup, Drive like an SUV,” the RD6 PHEV combines strong performance with everyday usability. It accelerates from 0 to 100 km/h in 6.3 seconds. Intelligent electric all-wheel drive and multiple terrain modes ensure confident handling in demanding road conditions. With a rated payload of 875 kg and a towing capacity of 2.5 tons, the model supports agricultural, mining, and logistics operations. A combined driving range of over 1,000 km and vehicle-to-load capability further enhance efficiency in daily and commercial use.

    Alongside its overseas expansion, Geely RIDDARA continues to lead China’s new energy pickup market. Sales data released in January 2025 show the brand achieved a 52.2% market share in the new energy pickup segment and an 82.8% share in the pure electric pickup segment, ranking first for three consecutive years (source: CATARC). Building on this foundation, Geely RIDDARA is accelerating the global rollout of its technologies and products, reinforcing its commitment to delivering efficient and reliable new energy pickup solutions worldwide.

  • Global Hitmaker KEN WILL Releases New Single “Coffee” via Warner Music Group on February 27, 2026

    New York, NY — February 24, 2026 — Warner Music Group (WMG) today announced the release of “Coffee,” the new single from global hitmaker KEN WILL, arriving worldwide on February 27, 2026, across all major streaming platforms.

    The release comes amid a strong start to 2026 for Warner Music Group, reinforcing the company’s continued momentum across its global roster. With “Coffee,” KEN WILL delivers a defining statement record that underscores his creative range and expanding international footprint.

     

    Blending contemporary R&B; with refined pop minimalism, “Coffee” pairs atmospheric textures with precise, controlled vocal delivery. Built around the metaphor of a late-night ritual, the single explores themes of intimacy, vulnerability, and emotional clarity through immersive production.

    Subtle percussion, layered harmonies, and restrained sonic architecture create a soundscape that is both modern and timeless.

     

    “KEN WILL represents a rare combination of commercial instinct and artistic independence,” said a spokesperson for Warner Music Group. “With ‘Coffee,’ he continues to establish himself as a creative force while signaling the next chapter in his global trajectory.”

     

    Since signing with Warner Music Group in December 2025, KEN WILL has been developing a focused international rollout strategy aimed at amplifying his presence across key global markets. “Coffee” marks a significant milestone in that partnership and sets the tone for an ambitious 2026 campaign.

     

    The single will be supported by a coordinated multi-platform launch, including strategic streaming partnerships, premium visual content, and targeted audience engagement initiatives designed to maximize global reach.

     

    “Coffee” will be available beginning at 12:00 AM local time on February 27, 2026, via Spotify, Apple Music, Amazon Music, and all major digital service providers.

     

    For press inquiries, interview requests, or additional information, please contact Warner Music Group’s press office.

     

    About Warner Music Group

     

    Warner Music Group is a global leader in recorded music, music publishing, and artist services, representing a diverse roster of acclaimed and emerging artists worldwide.

     

    About KEN WILL

     

    KEN WILL is a globally recognized singer, songwriter, and producer known for blending contemporary R&B; with modern pop sensibility. Signed to Warner Music Group in December 2025, he continues to shape his sound through releases that merge emotional authenticity with refined sonic craftsmanship.

     

    KEN WILL Releases Single “Coffee” Release Date: February 27, 2026 Single Title: Coffee

    Label: Warner Music Group (WMG)

  • KEN WILL Releases New Single “Coffee” via Warner Music Group on February 27, 2026

    New York, NY — February 24, 2026 — Warner Music Group (WMG) today announced the release of “Coffee,” the new single from global hitmaker KEN WILL, arriving worldwide on February 27, 2026, across all major streaming platforms.

    The release comes amid a strong start to 2026 for Warner Music Group, reinforcing the company’s continued momentum across its global roster. With “Coffee,” KEN WILL delivers a defining statement record that underscores his creative range and expanding international footprint.

     

    Blending contemporary R&B; with refined pop minimalism, “Coffee” pairs atmospheric textures with precise, controlled vocal delivery. Built around the metaphor of a late-night ritual, the single explores themes of intimacy, vulnerability, and emotional clarity through immersive production.

    Subtle percussion, layered harmonies, and restrained sonic architecture create a soundscape that is both modern and timeless.

     

    “KEN WILL represents a rare combination of commercial instinct and artistic independence,” said a spokesperson for Warner Music Group. “With ‘Coffee,’ he continues to establish himself as a creative force while signaling the next chapter in his global trajectory.”

     

    Since signing with Warner Music Group in December 2025, KEN WILL has been developing a focused international rollout strategy aimed at amplifying his presence across key global markets. “Coffee” marks a significant milestone in that partnership and sets the tone for an ambitious 2026 campaign.

     

    The single will be supported by a coordinated multi-platform launch, including strategic streaming partnerships, premium visual content, and targeted audience engagement initiatives designed to maximize global reach.

     

    “Coffee” will be available beginning at 12:00 AM local time on February 27, 2026, via Spotify, Apple Music, Amazon Music, and all major digital service providers.

     

    For press inquiries, interview requests, or additional information, please contact Warner Music Group’s press office.

     

    About Warner Music Group

     

    Warner Music Group is a global leader in recorded music, music publishing, and artist services, representing a diverse roster of acclaimed and emerging artists worldwide.

     

    About KEN WILL

     

    KEN WILL is a globally recognized singer, songwriter, and producer known for blending contemporary R&B; with modern pop sensibility. Signed to Warner Music Group in December 2025, he continues to shape his sound through releases that merge emotional authenticity with refined sonic craftsmanship.

     

    KEN WILL Releases Single “Coffee” Release Date: February 27, 2026 Single Title: Coffee

    Label: Warner Music Group (WMG)

  • CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China

    SHENZHEN, CHINA China Medical System Holdings Limited (CMS” or the Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received the acceptance from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (the Product”) for the treatment of mild to moderate atopic dermatitis on 24 February 2026. The Product is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. The NDA has been approved for inclusion in the Priority Review List by the Center for Drug Evaluation (CDE) of the NMPA based on its qualification as a new variety, dosage form and specification of pediatric drug that conforms to the physiological characteristics of children”, which is expected to accelerate the Product’s review process for marketing approval in the AD indication.

     

    Impressive phase III trial data in AD

    Its Priority Review is expected to accelerate its NDA approval

     

    Ruxolitinib phosphate cream was approved for marketing by the NMPA in January 2026, becoming the first and only targeted drug approved in China for the treatment of vitiligo. The acceptance of this NDA for the additional indication of AD marks a key milestone in the Product’s expansion into multiple therapeutic areas.

     

    Ruxolitinib phosphate cream has achieved positive results in a randomized, double-blind, placebo-controlled Phase III clinical trial in China for mild to moderate AD.

    1. Robust Efficacy: The Product successfully met its primary endpoint, demonstrating that a significantly higher proportion of subjects treated with ruxolitinib phosphate cream achieved IGA (Investigator’s Global Assessment) of 0 or 1 with at least two grades of reduction from baseline at week 8, compared with placebo (63.0% vs 9.2%, P < 0.001). For the key secondary endpoint, the proportion of subjects achieving at least a 75% improvement from baseline in the Eczema Area and Severity Index score (EASI 75) of treatment with ruxolitinib phosphate cream was also significantly higher than that of the placebo group, at week 8 (78.0% vs 15.4%, P < 0.001).
    2. Favorable Safety Profile: The severity of treatment-emergent adverse events (TEAE) during the treatment period was mostly mild or moderate, with no TEAEs leading to discontinuation of the study drug. Overall, ruxolitinib phosphate cream was safe and well-tolerated.

     

    Furthermore, the NDA has been approved for inclusion in the Priority Review List. According to relevant NMPA regulations, the review timeline for marketing applications subject to Priority Review and Approval Procedure is substantially shortened—from the standard 200 days to 130 days. This significant reduction in the review timeline is expected to accelerate the marketing process of ruxolitinib phosphate cream for the AD indication, benefiting a wide range of patients at an earlier date.

     

    Building an integrated AD solution,

    strengthening Dermavons leadership in dermatology

     

    AD is a chronic, recurrent and inflammatory dermatologic disease, with the main clinical manifestations of dry skin, chronic eczema-like lesions and obvious itching or pruritus, which may seriously affect the quality of life of patients. It is estimated that there were over 54 million AD patients in China as of 2024. Based on SCORAD scores, mild to moderate AD accounts for 98% of these cases, representing over 52.5 million patients[1]. Topical drugs are the most basic treatment for AD. Traditional topical medications such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs) have clinical pain points with long-term adverse reactions or limited efficacy, therefore novel treatments are urgently needed.

     

    Dermavon has developed a comprehensive treatment + care” integrated solution for AD. In addition to the topical formulation ruxolitinib phosphate cream for mild-to-moderate AD, the portfolio also includes the injectable biological agent Comekibart Injection (MG-K10) for moderate-to-severe AD, the oral small molecule targeted drug CMS-D001 for moderate-to-severe AD, and the Heling Soothing Product Series for daily repair, to meet the management needs of AD patients from treatment to daily care.

     

    Simultaneously, the acceptance of the NDA for the AD indication will strengthen Dermavon’s strategic layout in the field of skin treatments and create synergies with its commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s market competitiveness and brand influence in the field of skin health.

     

    More Information About Ruxolitinib Phosphate Cream

    Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte. In China, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. In the U.S., ruxolitinib phosphate cream is the first topical JAK inhibitor approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of non-segmental vitiligo in patients aged 12 years and older, and for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable[2]. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[3].

     

    The Group, through its subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary).

     

    Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.

     

     

    About CMS

     

    CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

     

    CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

     

    CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.

     

    Reference:

    1. China Insights Consultancy’s industrial report

    2. The U.S. FDA approval information can be found on the Incyte official website, as follows:

    https://investor.incyte.com/news-releases/news-release-details/incyte-announces-additional-fda-approval-opzelurar-ruxolitinib

    3. The EMA approval information can be found on the Incyte official website, as follows:

    https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar

     

     

    CMS Disclaimer and Forward-Looking Statements

     

    This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

    This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Groups market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

     

    Media Contact

    Brand: China Medical System Holdings Ltd.

    Contact: CMS Investor Relations

    Email: ir@cms.net.cn

    Website: https://web.cms.net.cn/en/home/

     

  • DhanX Vision 2026 Summit Concludes Successfully, Showcasing Innovation, Community Growth, and Future Collaboration

    Mumbai, India — The DhanX Vision 2026 Summit concluded on a high note following a successful gathering of global partners, community leaders, technology advocates, and invited guests. The landmark event marked an important milestone for the organization, highlighting its growth journey, collaborative ecosystem, and forward-looking vision for the years ahead.

     

    Hosted in Mumbai, the summit drew strong participation from attendees across India and international markets. The event created a vibrant platform for dialogue, knowledge sharing, and relationship building, reinforcing DhanX’s commitment to

    fostering a connected and future-ready global community.

     

    The summit commenced with an opening address from senior leadership, who reflected on the organization’s journey and its mission to drive innovation through technology-enabled platforms. Speakers emphasized the importance of accessibility, collaboration, and long-term sustainability in building digital ecosystems that serve real-world communities.

     

    Throughout the day, attendees were introduced to the broader DhanX platform framework, including its digital infrastructure, user engagement initiatives, and ecosystem development strategy. Presentations focused on how emerging

    technologies, digital platforms, and community-driven participation can work together to unlock new opportunities for individuals and organizations alike.

     

    One of the central highlights of the summit was the preview of upcoming platform enhancements designed to improve user experience, expand service capabilities, and strengthen ecosystem connectivity. Demonstrations showcased how technology is being leveraged to streamline participation, enhance transparency, and create more inclusive digital environments.

     

    In addition to technology showcases, the event placed strong emphasis on community growth and leadership development. Updates were shared on regional outreach programs, educational initiatives, and offline engagement efforts that have helped expand the platform’s presence across multiple markets.

     

    A special recognition segment honored community leaders, partners, and contributors who have played key roles in supporting ecosystem development. Awards were presented to individuals and teams who demonstrated excellence in leadership, education, and organizational growth within their regions.

     

    The summit also featured panel discussions and sharing sessions centered on digital transformation, innovation trends, and the role of emerging platforms in shaping

    future industries. These sessions encouraged open dialogue, allowing participants to exchange insights, experiences, and ideas for collaborative progress.

     

    Another major announcement during the event was the unveiling of the Vision 2026 Strategic Roadmap. This roadmap outlines the organization’s phased development plan, including expansion into new markets, enhancement of platform services, and the introduction of initiatives aimed at strengthening global partnerships and community infrastructure.

     

    Leadership highlighted that the roadmap is designed not only to scale operations but also to create long-term value through innovation, education, and responsible ecosystem building. The focus remains on sustainable growth supported by strong partnerships and active community participation.

     

    Industry observers and invited guests noted the scale, professionalism, and organizational depth demonstrated throughout the summit. From event production to speaker presentations and partner showcases, the gathering reflected a maturing ecosystem positioning itself for the next stage of international development.

     

    Beyond formal sessions, the summit provided valuable networking opportunities, enabling partners, leaders, and participants to connect, exchange perspectives, and explore future collaborations. The atmosphere throughout the event was marked by enthusiasm, optimism, and a shared commitment to innovation.

    As the summit drew to a close, leadership delivered a unifying message centered on progress through partnership. They reaffirmed that the future will be shaped by organizations and communities that embrace technology, collaboration, and forward- thinking leadership.

     

     

    The DhanX Vision 2026 Summit ultimately stood as more than a corporate event — it represented a celebration of shared achievements, a platform for meaningful engagement, and a launchpad for the next chapter of growth.

     

    With strong momentum, expanding partnerships, and a clear strategic roadmap, the organization now looks ahead to building on this success and continuing its mission of driving innovation and community empowerment on a global scale.

  • OHO SUNSHINE Secures ITC Termination After Complaint Withdrawal

    February 4, 2026 — OHO SUNSHINE today announced an update in U.S. International Trade Commission (“ITC”) Section 337 Investigation No. 337-TA-1455.

    According to public records, Complainant IngenioSpec, LLC filed a motion on December 1, 2025, to terminate the investigation as to Shenzhen Langzhiyin Electronic Co., Ltd. (doing business as OHO SUNSHINE) by withdrawing the complaint. On December 17, 2025, the presiding Administrative Law Judge issued Order No. 22, an Initial Determination granting the motion for termination as to OHO SUNSHINE.

     

    The Initial Determination granted the request to stay deadlines in the procedural schedule as they relate to OHO pending Commission review. The Commission subsequently determined on January 16, 2026, not to review the Initial Determination, and the investigation is terminated as to OHO.

    The investigation, as instituted, concerned allegations under Section 337 relating to certain electronic eyewear products and asserted patents, U.S. Patent Nos. 10,310,296 and 12,078,870.

    Throughout the process, OHO SUNSHINE maintained full cooperation with the proceedings and worked closely with its U.S. counsel, Rimon, P.C., to protect its lawful rights and interests. The company consistently maintained that the allegations lacked merit and emphasized that its products are independently developed, supported by its own innovation and intellectual property portfolio.

    Business operations, product deliveries, and customer support continue without interruption. Given the nature of legal proceedings, the company will not comment on non-public details. 

    About OHO SUNSHINE

    OHO SUNSHINE is a global smart eyewear brand created by Shenzhen Langzhiyin Electronic Co., Ltd., specializing in Bluetooth audio glasses, camera glasses, and AI translation eyewear. Originating from an OEM/ODM manufacturing background since 2009, the company has evolved into an independent global brand integrating advanced technology into stylish, everyday eyewear designs, serving customers worldwide with comprehensive shipping, warranty, and customer support.

    Media Contact: 

    OHO SUNSHINE
    Shenzhen
    Guangdong
    China
    +86 134 2287 6878
  • Chinese humanoid robots gallop towards consumer market

    CGTN published an article on robot performances during China Media Group’s 2026 Spring Festival Gala. When the Year of the Horse arrived in 2026, all eyes were on China’s Spring Festival Gala. What unfolded was more than a cultural spectacle – it was a hard-tech showcase. Humanoid robots have become a recurring Gala centerpiece, signaling China’s push for next-generation AI-powered robotics. While some Western counterparts remain stuck as expensive prototypes, China’s strategy is moving from lab to production line. The cycle from spectacle to store is complete – and the world is watching.

    Chinese humanoid robots have officially moved from lab prototypes to the center of the global stage.

    At this year’s CMG Spring Festival Gala, the world’s most-watched television broadcast, four Chinese robotics powerhouses, namely Unitree, MagicLab, Galbot and Noetix, debuted their most advanced units to date. For the robotics industry, this was far more than a cultural performance; it was a high-stakes global product launch.

    Global media hails China’s robot showcase

    The Associated Press noted that humanoid robots have become a recurring Spring Festival Gala centerpiece – a clear signal of “China’s push to develop more advanced robots powered by improved AI capabilities.”

    Major broadcasters like CBS praised the “seamless movements” of the units, while Spain’s El Español hailed the robots’ evolution from 2025 to 2026 as a “veritable revolution.” Last year’s robots were stiff and mechanical, but this year’s Unitree G1 units moved with fluidity and freedom, it said. The report also noted that the robots are commercial products – already available in Spain.

    A window to China’s industry policies

    The story of the “Gala Robot” can be traced as early as 2016 when the Shenzhen-based UBTECH debuted 540 small humanoid robots. By this year’s gala, the stage became unprecedentedly crowded with four distinct companies vying for a position.

    Fueled by breakthroughs in artificial intelligence, the humanoid robotics sector has advanced at a pace beyond expectations. CMG data shows that China recorded over 140 humanoid robot manufacturers in 2025 with more than 330 humanoid robot models launched.

    The explosion is a direct result of China’s humanoid industrial clusters, and this year’s performance reflects China’s industry policies, according to Reuters.

    In 2025, “embodied AI” was written into China’s Government Work Report for the first time, signaling its elevation to a top-tier strategic priority. This momentum was further solidified in the Recommendations of the Communist Party of China Central Committee for Formulating the 15th Five-Year Plan for National Economic and Social Development, which identified embodied AI among “new drivers of economic growth.”

    Following this central guidance, local governments across China have rapidly integrated humanoid robotics into their economic blueprints, rolling out specialized support policies and incentives to secure a leading position in this high-stakes global race.

    Reshaping the global industrial landscape

    In the sketch comedy, Noetix’s “Bumi” robot navigated the nuances of a family skit, using humor to bridge the gap between a machine and a companion. In the short film, the robot was shown performing chores in a real-world home.

    “Ultimately, technology is meant to serve people, not just exist for the sake of the technology itself,” Unitree’s founder Wang Xingxing said in an interview with CMG.

    This vision is already translating into massive market demand. Within the first two hours of the Gala’s broadcast, searches for robots on an e-commerce platform surged more than 300 percent compared to the previous period. Customer inquiries increased by 460 percent, and order volumes rose by 150 percent. The new orders covered over 100 cities nationwide, spanning from first-tier metropolises to smaller counties.

    Noetix CMO Zhang Miao explained to the press that China has moved from the factory floor to the commercial channel. “The real measure of a company’s health is no longer how many robots it can build, but how many it can successfully integrate into real-world scenarios.”

    A new era of robotics is now taking shape – and it is firmly rooted in China.

    For more information, please click:

    https://news.cgtn.com/news/2026-02-17/China-s-robots-ready-to-walk-off-the-stage-and-into-a-store-near-you-1KQnpNZa8Io/p.html

  • When Gatekeepers Exploit the Public Markets: How Aggressive Micro-Cap Structuring Ruined It for Everyone

    The micro-cap IPO window did not close by accident. It did not shut because investors suddenly lost interest in growth companies, nor because capital vanished from the system. It narrowed because structural flexibility was pushed too far, for too long, and in ways that ultimately forced a response.

    Between 2021 and 2025, U.S. IPO activity moved through distinct but related phases, with a meaningful share concentrated in small and micro-cap offerings. The early part of that period was marked by abundant liquidity and elevated risk appetite. Capital was readily available, speculative enthusiasm was high, and smaller issuers found receptive audiences. As broader market conditions tightened — rising rates, declining valuations, and more selective institutional capital — access became more constrained. But micro-cap deal activity did not disappear. Instead, structures became more complex, more aggressive, and in some cases more dependent on volatility itself to sustain capital formation.

    Many of these offerings raised under $50 million. Some were far smaller. On the surface, the activity suggested that emerging companies still had viable pathways into the public markets even as larger IPO windows fluctuated. It appeared to represent resilience at the smallest tier of the exchange ecosystem.

    But beneath that surface, structural vulnerabilities were becoming increasingly visible.

    Low public float, thin liquidity, layered financing instruments, and capital structures highly sensitive to short-term trading dynamics created an environment where price spikes were common and reversals were swift. In some instances, the very features that made entry possible also amplified instability after listing. Retail investors frequently entered during upward momentum, only to encounter dilution cycles and sharp corrections once financing mechanisms were triggered.

    By 2024 and into 2025, the pattern was difficult to ignore. When volatility-dependent structures repeat across multiple issuers and produce similar outcomes, exchanges and regulators inevitably respond.

    To understand why the window narrowed, it is necessary to examine how certain gatekeepers operated during this multi-year cycle.

     

    Why This Needs to Be Said

    Much of this is acknowledged privately among market professionals but rarely articulated openly. The tightening of the micro-cap IPO market did not occur in isolation. It followed several years in which structural flexibility was tested — and in some cases stretched — to the outer edge of what the public markets would absorb.

    When deal structures prioritize maximum short-term extraction over long-term durability, the consequences extend well beyond any single transaction. The ripple effects are systemic.

    Legitimate small-cap companies that genuinely seek to use public markets for growth now face higher barriers because flexibility that once existed was leaned on too aggressively. Retail investors who want exposure to early-stage stories have grown more skeptical — understandably — after repeated volatility cycles that ended in heavy dilution and sharp declines. And securities attorneys who operate ethically, structure balanced offerings, and prioritize sustainable capital formation now work within a framework shaped by reforms triggered by more aggressive actors.

    This is not an indictment of an entire profession. There are capable, principled attorneys who protect issuers and investors alike. But when a segment of the market exploits structural weaknesses — whether through excessively dilutive terms, volatility-sensitive financing, or capital raises timed around artificial momentum — the regulatory response applies broadly. It does not isolate the careful from the careless.

     

    Exploiting the Structure of Micro-Cap Markets

    Securities attorneys and placement professionals play a central role in shaping capital formation. They structure offerings, negotiate financing terms, design warrant packages, and guide issuers through public listings. When executed responsibly, this work strengthens market integrity and protects both issuers and investors.

    During the 2021–2025 cycle, however, some market participants leaned heavily into vulnerabilities inherent in the smallest tier of the public markets.

    Deeply discounted offerings layered onto thin floats. Highly dilutive convertible instruments structured to benefit from volatility. Heavy warrant coverage tied to elevated trading windows. Capital raises executed during price surges rather than tied to operational milestones.

    This did not describe every firm or every transaction. Many advisors insist on durable, balanced structures. But in competitive environments, issuers under financial pressure gravitate toward the most permissive structure available. If one advisor is willing to push further — offering fewer constraints and more aggressive economics — the incentives become self-reinforcing.

    Businesses generally pursue the structure that raises the most capital under the least restrictive terms. When thin float, retail momentum, and volatility can be leveraged to maximize proceeds, the temptation is obvious.

    The outcomes, over time, became predictable.

     

    The Volatility–Offering Cycle

    In a low-float environment, even modest buying pressure can send a stock materially higher. Add promotional energy — optimistic press releases, speculative commentary, retail enthusiasm — and price discovery can detach from fundamentals with surprising speed.

    A familiar sequence often followed: a sharp upward move; an offering or capital raise executed near elevated levels; warrant exercises or conversions; significant dilution; and then a rapid reversal as new supply overwhelmed demand.

    Retail investors frequently entered during the surge, believing the move reflected genuine operational progress or transformative developments. In many cases, disclosures were technically compliant but structurally incomplete in terms of explaining how financing mechanics would affect shareholders during inevitable volatility.

    When the reversal came — as thinly traded micro-caps often experience — retail participants were left holding losses amplified by capital structures designed to reset, reprice, or convert during weakness.

    The issue was not geography. It was not limited to foreign issuers. U.S.-based micro-caps have exhibited similar cycles across decades. The common denominator was structure — and how that structure was used.

     

    PIPE Financing: When a Tool Becomes a Weapon

    Private Investment in Public Equity (PIPE) financings were originally intended as efficient capital formation tools. In principle, they allow public companies — particularly smaller issuers — to raise capital quickly without undertaking a full public offering. When structured responsibly, PIPEs can provide flexibility to companies navigating early growth phases.

    But during the multi-year micro-cap cycle, these instruments were at times engineered in ways that diverged sharply from that purpose.

    Deep discounts, floating-rate convertibles, reset provisions tied to future trading prices, and heavy warrant coverage can create incentives fundamentally misaligned with long-term shareholders. In thin-float securities, these features can produce a self-reinforcing loop: volatility attracts financing; financing introduces dilution; dilution pressures price; conversion formulas reset lower; and the cycle continues.

    The structure becomes volatility-dependent.

    This is not a blanket condemnation of PIPE transactions. Many are negotiated fairly and disclosed transparently. The concern arises when financing instruments are repeatedly designed in ways that appear to benefit from predictable dilution and instability — particularly in companies with limited operating scale.

    Public markets tolerate dilution when it funds growth. They do not function well when financing mechanics depend on volatility and repeated resets to generate return.

    When sophisticated professionals structure or facilitate such transactions repeatedly — especially where patterns become visible across multiple issuers — fines alone are unlikely to alter behavior. Monetary settlements absorbed as a cost of doing business do not deter systemic exploitation.

    In cases involving intentional misrepresentation, undisclosed conflicts, coordinated dilution cycles, or market manipulation, consequences should extend beyond financial penalties. Industry bars, professional discipline, and — where evidence supports it — prosecution are not excessive measures. They are necessary protections.

    Gatekeepers exist because markets rely on professionals to prevent predictable harm. When they instead enable it, meaningful accountability is essential.

     

    Why Exchanges Responded

    Exchanges did not tighten standards based on theory. They responded to observable fragility accumulated over several years.

    Listing thresholds increased. Requirements surrounding unrestricted publicly held shares became more demanding. Continued listing standards — including minimum bid price and market value thresholds — were enforced more rigorously. Exchanges expanded qualitative discretion where structural concerns suggested heightened manipulation risk.

    The entry threshold rose. The survival threshold rose. Ultra-thin, volatility-dependent pathways became significantly more difficult to execute.

    From a systemic perspective, the shift is understandable. Markets cannot function if confidence erodes at their foundation. But the tightening did not isolate only aggressive actors. It reshaped the environment for everyone operating within it.

    The Collateral Consequences

    When structural flexibility is exploited repeatedly, corrective responses are rarely surgical.

    Legitimate small companies now face higher capital barriers. Responsible advisors operate in a more restrictive framework. Retail investors approach micro-cap growth stories with heightened skepticism. The ecosystem adjusts collectively.

    That is the quiet cost of exploitation.

    The Larger Lesson

    Public markets are sustained not only by disclosure, but by structure. When companies are engineered in ways that rely on volatility to raise capital, when financing mechanics amplify dilution during price spikes, and when retail investors repeatedly absorb asymmetric downside, confidence deteriorates.

    Micro-cap IPOs still exist. Access has not disappeared. But it is no longer as permissive as it once was.

    That shift was not random. It was the product of incentives pushed too far over a multi-year cycle — and structures leaned on too heavily.

    Integrity sustains access.

    Exploitation, eventually, closes the window for everyone.

    Media Contact: 

    Matt Miller
    Strategic Risk LLC
    Bronx
    NY
    United States
    9143064771
  • Launch of Fresh Online Casino Guide for South Africa 2026

    SouthAfricanCasinos.co.za, the leading gambling guide for South Africans that has been operating since 2003, has published its refreshed 2026 online casino guide—built to help players navigate gambling in South Africa with clearer bonus explanations, ZAR-friendly banking tips, and a curated shortlist of standout brands.

    The update is designed around what players are searching for most as the year kicks off: south africa online casino options, free spins, and “free no deposit” style offers that let new players try a site before committing meaningful funds. SouthAfricanCasinos.co.za says its new-year refresh brings those topics together in one place—alongside a stronger focus on practical “what to check first” guidance for anyone hunting for a casino in South Africa (or a ZAR-focused online casino experience).

    What’s New in the 2026 Guide

    SouthAfricanCasinos.co.za’s 2026 update centres on three improvements aimed at making bonus-led casino browsing less confusing:

    • A clearer bonus hub that highlights popular promotion types—especially free spins and free no deposit bonus offers—while explaining how these bonuses typically work, which games they apply to, and why they’re so popular with South African-facing players.
    • More ZAR and banking context, with content that focuses on South African-facing play patterns and common payment expectations (especially around local, familiar deposit options).
    • A tightened “Star List” of brands the site is spotlighting in 2026—chosen for specific reasons (bonuses, mobile play, game libraries, or all-in-one betting + casino access).

    2026 Star List: The Brands SouthAfricanCasinos.co.za is Spotlighting

    SouthAfricanCasinos.co.za’s 2026 star list focuses on what players actually care about when choosing an online casino in South Africa: the strength of the welcome offer, the quality of the games, how easy it is to understand bonus terms, and whether the platform feels reliable once you move beyond the headline promo. It’s a curated shortlist for people comparing a casino in South Africa and looking for value in bonuses like free spins no deposit and free no deposit offers—without the fluff.

     

    Hollywoodbets

    Best for: A quick, low-commitment start. Hollywoodbets free R25 sign-up bet makes it easy to jump in, and the addition of Evolution live casino content gives it a premium, real-table feel. The refer-a-friend perk is a nice extra for players who like sharing a good find.

    Springbok Casino

    Best for: Big headline value. SouthAfricanCasinos.co.za spotlights springbok casino for its exclusive R500 free no deposit bonus, backed by a larger welcome package (up to R11,500) and a deep RTG catalogue with 400+ Rand-based games.

    ZARbet

    Best for: Free spins + variety. The guide highlights 50 free spins on Big Blue Fishing (with a coupon code) and a 125% match bonus up to R3,750 at ZARbet, plus a strong provider mix that includes NetEnt, Red Tiger, and Evolution.

    Lucky Fish

    Best for: A simple “test the waters” offer. SouthAfricanCasinos.co.za highlights Lucky Fish Casino for its R50 free sign-up bonus and a studio mix including NetEnt, Red Tiger, and Evolution—ideal if you want something straightforward without wading through messy bonus terms.

    Yebo Casino

    Best for: Bonus-first play with credibility signals. SouthAfricanCasinos.co.za highlights Yebo for 200+ RTG games and references to recognised testing/certification bodies (including TST and GLI) that many players look for when judging fairness. Yebo Casino also promotes a no deposit bonus code tied to a featured slot experience, alongside broader bonus messaging that includes free spins.

    Pantherbet

    Best for: One-account convenience. SouthAfricanCasinos.co.za frames Pantherbet as an all-in-one option for players who like switching between sports and casino without juggling multiple logins.

    Punt Casino

    Best for: A strong free-no-deposit hook. Punt Casino guide highlights an exclusive R350 free no deposit bonus, paired with 200+ tested games including blackjack, roulette, and slots—ideal for “try before you commit” players.

    YesPlay

    Best for: A broader entertainment platform. SouthAfricanCasinos.co.za positions YesPlay Casino as combining casino, lotteries, and sports betting, while still offering 200+ live-dealer and RNG casino games for players who want variety in one place.

    How the 2026 Star List is Chosen

    Rather than chasing hype, SouthAfricanCasinos.co.za’s 2026 refresh focuses on practical player priorities: how easy a site is to use on mobile, how clear the bonus terms are, whether payments and withdrawals feel straightforward, the quality of the game library (including live casino where available), and whether support is responsive when something goes wrong. The star list highlights brands that perform well across these day-to-day criteria, with each operator featured for a specific standout strength.

    What SouthAfricanCasinos.co.za Says:

    “Players are coming into 2026 looking for two things: a smoother online casino experience and clearer answers on bonuses,” a SouthAfricanCasinos.co.za spokesperson said. “This guide refresh is about cutting through the noise—highlighting our star list, explaining free spins and free no deposit casino bonus offers in plain language, and helping people understand what they’re actually signing up for.”

    Website

    southafricancasinos.co.za

    18+ only. Gambling can be addictive. Please play responsibly.